118 related articles for article (PubMed ID: 12416648)
41. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
42. [Effect of salpingectomy on the results of IVF in women with tubal sterility--prospective study].
Mardesić T; Muller P; Huttelová R; Zvárová J; Hulvert J; Voboril J; Becvárová V; Miková M; Landová K; Jirkovský M
Ceska Gynekol; 2001 Jul; 66(4):259-64. PubMed ID: 11569422
[TBL] [Abstract][Full Text] [Related]
43. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.
Balasch J; Fábregues F; Creus M; Peñarrubia J; Vidal E; Carmona F; Puerto B; Vanrell JA
J Assist Reprod Genet; 2000 Jan; 17(1):20-7. PubMed ID: 10754779
[TBL] [Abstract][Full Text] [Related]
44. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
45. Progestin exposure before gonadotropin stimulation improves embryo development after in vitro fertilization in the domestic cat.
Pelican KM; Spindler RE; Pukazhenthi BS; Wildt DE; Ottinger MA; Howard J
Biol Reprod; 2010 Oct; 83(4):558-67. PubMed ID: 20463355
[TBL] [Abstract][Full Text] [Related]
46. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
[TBL] [Abstract][Full Text] [Related]
47. Consecutive cycles in in vitro fertilization--embryo transfer.
Doldi N; Persico P; De Santis L; Rabellotti E; Papaleo E; Ferrari A
Gynecol Endocrinol; 2005 Mar; 20(3):132-6. PubMed ID: 16019351
[TBL] [Abstract][Full Text] [Related]
48. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
[TBL] [Abstract][Full Text] [Related]
49. [Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer].
Chen SL; Xia R; Chen X; Luo YQ; Wang LL; Wu YQ; Shi XY; Zheng HY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):572-7. PubMed ID: 21515446
[TBL] [Abstract][Full Text] [Related]
50. Increasing the stimulation dose of rFHS in unexpected poor responders is not associated with better IVF outcome.
Tutuncu L; Dundar O
Ginekol Pol; 2012 Feb; 83(2):111-5. PubMed ID: 22568355
[TBL] [Abstract][Full Text] [Related]
51. Contralateral selection of dominant follicle favours pre-embryo development.
Fukuda M; Fukuda K; Andersen CY; Byskov AG
Hum Reprod; 1996 Sep; 11(9):1958-62. PubMed ID: 8921071
[TBL] [Abstract][Full Text] [Related]
52. Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease.
Bider D; Hourvitz A; Tur Kaspa I; Dirnfeld M; Dor J
J Assist Reprod Genet; 1999 May; 16(5):233-5. PubMed ID: 10335468
[TBL] [Abstract][Full Text] [Related]
53. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
[TBL] [Abstract][Full Text] [Related]
54. Effect of salpingectomy on ovarian response to hyperstimulation during in vitro fertilization: a meta-analysis.
Fan M; Ma L
Fertil Steril; 2016 Aug; 106(2):322-329.e9. PubMed ID: 27114330
[TBL] [Abstract][Full Text] [Related]
55. Do poor-responder patients benefit from increasing the daily gonadotropin dose during controlled ovarian hyperstimulation for IVF?
Haas J; Zilberberg E; Machtinger R; Kedem A; Hourvitz A; Orvieto R
Gynecol Endocrinol; 2015 Jan; 31(1):79-82. PubMed ID: 25223892
[TBL] [Abstract][Full Text] [Related]
56. [Factors related to occurrence of twin pregnancy after double-embryo transfer in vitro fertilization cycles].
Niu ZH; Feng Y; Zhang AJ; Zhang HQ; Sun YJ; Lu XW
Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):413-7. PubMed ID: 19953939
[TBL] [Abstract][Full Text] [Related]
57. [Protocol of GNRH antagonist in poor responders in IVF-ET cycles].
Grzechocińska B; Fracki S; Marianowski P; Dworniak T; Bablok L; Marianowski L
Ginekol Pol; 2003 Sep; 74(9):943-8. PubMed ID: 14674149
[TBL] [Abstract][Full Text] [Related]
58. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
59. A controlled ovarian hyperstimulation regimen involving intermittent gonadotropin administration with a "short" protocol of gonadotropin releasing hormone agonist for in vitro fertilization.
Suganuma N; Tsukahara SI; Kitagawa T; Furuhashi M; Asada Y; Kondo I
J Assist Reprod Genet; 1996 Jan; 13(1):43-8. PubMed ID: 8825166
[TBL] [Abstract][Full Text] [Related]
60. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation.
Ho HY; Lee RK; Hwu YM; Lin MH; Su JT; Tsai YC
J Assist Reprod Genet; 2002 Nov; 19(11):507-11. PubMed ID: 12484492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
